SITC2024

会議名 : SITC's 39th Annual Meeting & Pre-Conference Programs (SITC 2024)
演題 : Preferential targeting of HER2-expressing cancer cells by FT825/ONO-8250, an off-the-shelf iPSC-derived CAR-T cell incorporating novel synthetic mechanisms for enhanced solid tumor activity
発表者：Martin P Hosking, Takao Arimori, Soheila Shirinbak, Kyla Omilusik, Shilpi Chandra, Cara Bickers, Mika K. Kaneko, Angela Gentile, Mohamed Elgendy, Bertha Villa, Zahid Bashir, Rebecca Elstrom, Susumu Yamamoto, Takahiro Mizoguchi, Tatsuya Ihara, Daisuke Nakayama, Lilly Wong, Jode Goodridge, Tatsuo Maeda, Junichi Takagi, Yukinari Kato, Bahram Valamehr（口頭発表＜pick up＞；ポスター発表）
期日 : November, 9th, 2024
会場 : Houston 
 

 

Nov 9, 2024

When: November 9, 2024 | 12:30 PM - 1:30 PM CT | Where: George R. Brown Convention Center Level 3 - Grand Ballroom B

This fast-paced session will feature six oral presentations from select basic science abstracts with time for Q&A. Co-Chairs: Nicole Scharping, PhD - University of California San Diego Aleksei Tikhonov, PhD - Gustave Roussy

205a: Rapid Oral - Basic 2

(269) Preferential targeting of HER2-expressing cancer cells by FT825/ONO-8250, an off-the-shelf iPSC-derived CAR-T cell incorporating novel synthetic mechanisms for enhanced solid tumor activity 12:46 PM - 12:54 PM
Martin Hosking, PhD
Fate Therapeutics, Inc.
Presenting Author
12:46 PM - 12:54 PM(269) Preferential targeting of HER2-expressing cancer cells by FT825/ONO-8250, an off-the-shelf iPSC-derived CAR-T cell incorporating novel synthetic mechanisms for enhanced solid tumor activity